Diamant, M.
Amsterdam UMC Location Vrije Universiteit Amsterdam
12 papers on CoChat
Most cited papers
- Verified
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 3,919
- Verified
Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options?
Van Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation
Adrenal Hormones and DisordersAdipokines, Inflammation, and Metabolic Diseases
Cited by 439
- Verified
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
van Bloemendaal, L., ten Kulve, J. S., la Fleur, S. E., Ijzerman, R. G., & Diamant, M. (2014) · Journal of Endocrinology
Regulation of Appetite and ObesityDiabetes Treatment and Management
Cited by 312
- Verified
Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
Diamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews
Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases
Cited by 308
- Verified
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats
Ouwens, D. M., Boer, C., Fodor, M., de Galan, P., Heine, R. J., Maassen, J. A., & Diamant, M. (2005) · Diabetologia
Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 256
- Verified
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans
van Bloemendaal, L., Veltman, D. J., ten Kulve, J. S., Groot, P. F. C., Ruhé, H. G., Barkhof, F., Sloan, J. H., Diamant, M., & Ijzerman, R. G. (2015) · Diabetes, Obesity and Metabolism
Regulation of Appetite and ObesityDiabetes Treatment and Management
Cited by 151
- Verified
Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial
van Raalte, D. H., Brands, M., van der Zijl, N. J., Muskiet, M. H., Pouwels, P. J. W., Ackermans, M. T., Sauerwein, H. P., Serlie, M. J., & Diamant, M. (2011) · Diabetologia
Adrenal Hormones and DisordersDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 109
- Verified
Acute renal haemodynamic effects of glucagon‐like peptide‐1 receptor agonist exenatide in healthy overweight men
Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Diamant, M., Joles, J. A., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 102
- Verified
Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial
Foley, J. E., Bunck, M. C., Möller-Goede, D. L., Poelma, M., Nijpels, G., Eekhoff, E. M., Schweizer, A., Heine, R. J., & Diamant, M. (2011) · Diabetologia
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 83
- Verified
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. Insulin glargine: A meta-analysis of seven clinical trials
Russell-Jones, D., Gall, M.-A., Niemeyer, M., Diamant, M., & Del Prato, S. (2015) · Nutrition, Metabolism and Cardiovascular Diseases
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 66
- Verified
Is insulin the most effective injectable antihyperglycaemic therapy?
Buse, J. B., Peters, A., Russell‐Jones, D., Furber, S., Donsmark, M., Han, J., MacConell, L., Maggs, D., & Diamant, M. (2015) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 32
- Verified
Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D. L., & van Raalte, D. H. (2017) · Diabetic Medicine
Diabetes Treatment and ManagementPancreatitis Pathology and Treatment
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free